Industry Research Reports

Home > Reports > Service & Software > Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-03-09

Pages: 106 Pages

Report ld: 6065942

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Genetic Disease Testing Market Size(US$)

CAGR 2026-2032

11.5%

Market Size,2032

USD 2,267

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 1,178 million

Market Forecast in 2032(Value)

US$ 2,267 million

CAGR

11.5%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Genetic Disease Testing was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 2267 million, growing at a CAGR of 11.5% from 2026 to 2032.

Genetic disease testing, also known as genetic testing, involves analyzing chromosomes, genes, or proteins to identify changes that may lead to genetic disorders. This testing can confirm or rule out suspected genetic conditions or assess the risk of developing or passing on genetic disorders.

Market Development Overview:

In recent years, the genetic disease testing market has seen substantial growth due to advances in genomics, increased awareness of genetic diseases, and growing demand for personalized medicine. The global genetic disease testing market was valued at billions of dollars in 2023 and is expected to expand at a significant compound annual growth rate (CAGR) in the coming years. Factors driving this growth include technological advances in next-generation sequencing (NGS), declining costs of genetic testing, and expanding applications in oncology, rare disease diagnosis, and reproductive health. Governments and healthcare organizations around the world are actively promoting genetic screening programs, further driving market expansion. Direct-to-consumer (DTC) genetic testing is also becoming increasingly popular, with companies offering home testing kits for health risk assessment and ancestry tracing. The market is expected to maintain steady growth as regulators create clearer guidelines for genetic testing services.

Market Development Opportunities:

Next-generation sequencing (NGS) and CRISPR gene editing technologies are revolutionizing genetic testing, enabling faster, more accurate, and more cost-effective diagnoses. The reduction in the cost of whole genome sequencing makes genetic testing more accessible to a wider range of people. As healthcare shifts toward personalized treatment plans, genetic testing is becoming an important tool to tailor treatments to patients’ genetic profiles. Precision oncology in particular benefits from genetic insights that enable targeted cancer treatments. Many rare genetic diseases remain undiagnosed due to the complexity of traditional diagnostic methods. Advances in genetic testing are improving early detection and management of these diseases, creating new market opportunities. With consumers’ growing interest in health and ancestry, demand for direct-to-consumer genetic testing companies has surged. Companies are also developing AI-driven analytics to provide more personalized insights from genetic data.

Market Risks and Challenges:

Genetic testing raises ethical questions about data privacy, consent, and potential misuse of genetic information. Governments are implementing stricter regulations, which could impact market growth if compliance costs increase. As genetic testing companies collect large amounts of sensitive personal data, the risk of data breaches and misuse continues to increase. Ensuring secure storage and ethical use of genetic data is a key concern for industry stakeholders. Despite declining sequencing costs, genetic testing remains expensive in many regions, limiting accessibility to low-income populations. Insurance coverage for genetic testing also varies, impacting adoption rates. Without appropriate genetic counseling, consumers and patients may misinterpret test results, leading to unnecessary anxiety or inappropriate medical decisions. Expanding access to genetic counseling services is critical to mitigating this risk.

This report provides a comprehensive view of the global market for Genetic Disease Testing, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Genetic Disease Testing market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Genetic Disease Testing.

MARKET SEGMENTATION

By Company

Invitae
Ambry Genetics
Exact Sciences
Qiagen
Tempus
23andme
Veritas Genetics
Myriad Genetics
LabCorp
Blueprint Genetics
Illumina
CENTOGENE
GeneDx
Fulgent Genetics
BGI Genomics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Direct Genetic Testing
Indirect Genetic Testing

Segment by Application

Carrier Testing
Prenatal Testing
Newborn Screening
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Genetic Disease Testing companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Genetic Disease Testing revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Genetic Disease Testing revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Genetic Disease Testing Product Introduction

1.2 Global Genetic Disease Testing Market Size Forecast (2021–2032)

1.3 Genetic Disease Testing Market Trends & Drivers

1.3.1 Genetic Disease Testing Industry Trends

1.3.2 Genetic Disease Testing Market Drivers & Opportunities

1.3.3 Genetic Disease Testing Market Challenges

1.3.4 Genetic Disease Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Genetic Disease Testing Players Revenue Ranking (2025)

2.2 Global Genetic Disease Testing Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Genetic Disease Testing Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Genetic Disease Testing

2.6 Genetic Disease Testing Market Competitive Analysis

2.6.1 Genetic Disease Testing Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Genetic Disease Testing Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Genetic Disease Testing revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Genetic Disease Testing Market Classification

3.1 Introduction by Type

3.1.1 Direct Genetic Testing

3.1.2 Indirect Genetic Testing

3.1.3 Global Genetic Disease Testing Sales Value by Type

3.1.3.1 Global Genetic Disease Testing Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Genetic Disease Testing Sales Value, by Type (2021–2032)

3.1.3.3 Global Genetic Disease Testing Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Carrier Testing

4.1.2 Prenatal Testing

4.1.3 Newborn Screening

4.1.4 Others

4.2 Global Genetic Disease Testing Sales Value by Application

4.2.1 Global Genetic Disease Testing Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Genetic Disease Testing Sales Value by Application (2021–2032)

4.2.3 Global Genetic Disease Testing Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Genetic Disease Testing Sales Value by Region

5.1.1 Global Genetic Disease Testing Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Genetic Disease Testing Sales Value by Region (2021–2026)

5.1.3 Global Genetic Disease Testing Sales Value by Region (2027–2032)

5.1.4 Global Genetic Disease Testing Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Genetic Disease Testing Sales Value, 2021–2032

5.2.2 North America Genetic Disease Testing Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Genetic Disease Testing Sales Value, 2021–2032

5.3.2 Europe Genetic Disease Testing Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Genetic Disease Testing Sales Value, 2021–2032

5.4.2 Asia Pacific Genetic Disease Testing Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Genetic Disease Testing Sales Value, 2021–2032

5.5.2 South America Genetic Disease Testing Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Genetic Disease Testing Sales Value, 2021–2032

5.6.2 Middle East & Africa Genetic Disease Testing Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Genetic Disease Testing Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Genetic Disease Testing Sales Value, 2021–2032

6.3 United States

6.3.1 United States Genetic Disease Testing Sales Value, 2021–2032

6.3.2 United States Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Genetic Disease Testing Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Genetic Disease Testing Sales Value, 2021–2032

6.4.2 Europe Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Genetic Disease Testing Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Genetic Disease Testing Sales Value, 2021–2032

6.5.2 China Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

6.5.3 China Genetic Disease Testing Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Genetic Disease Testing Sales Value, 2021–2032

6.6.2 Japan Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Genetic Disease Testing Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Genetic Disease Testing Sales Value, 2021–2032

6.7.2 South Korea Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Genetic Disease Testing Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Genetic Disease Testing Sales Value, 2021–2032

6.8.2 Southeast Asia Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Genetic Disease Testing Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Genetic Disease Testing Sales Value, 2021–2032

6.9.2 India Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

6.9.3 India Genetic Disease Testing Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Invitae

7.1.1 Invitae Profile

7.1.2 Invitae Main Business

7.1.3 Invitae Genetic Disease Testing Products, Services, and Solutions

7.1.4 Invitae Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.1.5 Invitae Recent Developments

7.2 Ambry Genetics

7.2.1 Ambry Genetics Profile

7.2.2 Ambry Genetics Main Business

7.2.3 Ambry Genetics Genetic Disease Testing Products, Services, and Solutions

7.2.4 Ambry Genetics Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.2.5 Ambry Genetics Recent Developments

7.3 Exact Sciences

7.3.1 Exact Sciences Profile

7.3.2 Exact Sciences Main Business

7.3.3 Exact Sciences Genetic Disease Testing Products, Services, and Solutions

7.3.4 Exact Sciences Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.3.5 Exact Sciences Recent Developments

7.4 Qiagen

7.4.1 Qiagen Profile

7.4.2 Qiagen Main Business

7.4.3 Qiagen Genetic Disease Testing Products, Services, and Solutions

7.4.4 Qiagen Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.4.5 Qiagen Recent Developments

7.5 Tempus

7.5.1 Tempus Profile

7.5.2 Tempus Main Business

7.5.3 Tempus Genetic Disease Testing Products, Services, and Solutions

7.5.4 Tempus Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.5.5 Tempus Recent Developments

7.6 23andme

7.6.1 23andme Profile

7.6.2 23andme Main Business

7.6.3 23andme Genetic Disease Testing Products, Services, and Solutions

7.6.4 23andme Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.6.5 23andme Recent Developments

7.7 Veritas Genetics

7.7.1 Veritas Genetics Profile

7.7.2 Veritas Genetics Main Business

7.7.3 Veritas Genetics Genetic Disease Testing Products, Services, and Solutions

7.7.4 Veritas Genetics Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.7.5 Veritas Genetics Recent Developments

7.8 Myriad Genetics

7.8.1 Myriad Genetics Profile

7.8.2 Myriad Genetics Main Business

7.8.3 Myriad Genetics Genetic Disease Testing Products, Services, and Solutions

7.8.4 Myriad Genetics Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.8.5 Myriad Genetics Recent Developments

7.9 LabCorp

7.9.1 LabCorp Profile

7.9.2 LabCorp Main Business

7.9.3 LabCorp Genetic Disease Testing Products, Services, and Solutions

7.9.4 LabCorp Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.9.5 LabCorp Recent Developments

7.10 Blueprint Genetics

7.10.1 Blueprint Genetics Profile

7.10.2 Blueprint Genetics Main Business

7.10.3 Blueprint Genetics Genetic Disease Testing Products, Services, and Solutions

7.10.4 Blueprint Genetics Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.10.5 Blueprint Genetics Recent Developments

7.11 Illumina

7.11.1 Illumina Profile

7.11.2 Illumina Main Business

7.11.3 Illumina Genetic Disease Testing Products, Services, and Solutions

7.11.4 Illumina Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.11.5 Illumina Recent Developments

7.12 CENTOGENE

7.12.1 CENTOGENE Profile

7.12.2 CENTOGENE Main Business

7.12.3 CENTOGENE Genetic Disease Testing Products, Services, and Solutions

7.12.4 CENTOGENE Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.12.5 CENTOGENE Recent Developments

7.13 GeneDx

7.13.1 GeneDx Profile

7.13.2 GeneDx Main Business

7.13.3 GeneDx Genetic Disease Testing Products, Services, and Solutions

7.13.4 GeneDx Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.13.5 GeneDx Recent Developments

7.14 Fulgent Genetics

7.14.1 Fulgent Genetics Profile

7.14.2 Fulgent Genetics Main Business

7.14.3 Fulgent Genetics Genetic Disease Testing Products, Services, and Solutions

7.14.4 Fulgent Genetics Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.14.5 Fulgent Genetics Recent Developments

7.15 BGI Genomics

7.15.1 BGI Genomics Profile

7.15.2 BGI Genomics Main Business

7.15.3 BGI Genomics Genetic Disease Testing Products, Services, and Solutions

7.15.4 BGI Genomics Genetic Disease Testing Revenue (US$ Million), 2021–2026

7.15.5 BGI Genomics Recent Developments

8 Industry Chain Analysis

8.1 Genetic Disease Testing Value Chain

8.2 Genetic Disease Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Genetic Disease Testing Sales Model

8.5.2 Sales Channels

8.5.3 Genetic Disease Testing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Genetic Disease Testing Market Trends

Table 2. Genetic Disease Testing Market Drivers & Opportunities

Table 3. Genetic Disease Testing Market Challenges

Table 4. Genetic Disease Testing Market Restraints

Table 5. Global Genetic Disease Testing Revenue by Company (US$ Million), 2021–2026

Table 6. Global Genetic Disease Testing Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Genetic Disease Testing Product Type

Table 9. Key Companies General Availability (GA) Timeline for Genetic Disease Testing

Table 10. Global Genetic Disease Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Genetic Disease Testing revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Genetic Disease Testing Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Genetic Disease Testing Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Genetic Disease Testing Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Genetic Disease Testing Sales Market Share in Value by Type (2021–2026)

Table 17. Global Genetic Disease Testing Sales Market Share in Value by Type (2027–2032)

Table 18. Global Genetic Disease Testing Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Genetic Disease Testing Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Genetic Disease Testing Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Genetic Disease Testing Sales Market Share in Value by Application (2021–2026)

Table 22. Global Genetic Disease Testing Sales Market Share in Value by Application (2027–2032)

Table 23. Global Genetic Disease Testing Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Genetic Disease Testing Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Genetic Disease Testing Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Genetic Disease Testing Sales Value by Region (%), 2021–2026

Table 27. Global Genetic Disease Testing Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Genetic Disease Testing Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Genetic Disease Testing Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Genetic Disease Testing Sales Value, (US$ Million), 2027–2032

Table 31. Invitae Basic Information List

Table 32. Invitae Description and Business Overview

Table 33. Invitae Genetic Disease Testing Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Genetic Disease Testing Business of Invitae (2021–2026)

Table 35. Invitae Recent Developments

Table 36. Ambry Genetics Basic Information List

Table 37. Ambry Genetics Description and Business Overview

Table 38. Ambry Genetics Genetic Disease Testing Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Genetic Disease Testing Business of Ambry Genetics (2021–2026)

Table 40. Ambry Genetics Recent Developments

Table 41. Exact Sciences Basic Information List

Table 42. Exact Sciences Description and Business Overview

Table 43. Exact Sciences Genetic Disease Testing Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Genetic Disease Testing Business of Exact Sciences (2021–2026)

Table 45. Exact Sciences Recent Developments

Table 46. Qiagen Basic Information List

Table 47. Qiagen Description and Business Overview

Table 48. Qiagen Genetic Disease Testing Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Genetic Disease Testing Business of Qiagen (2021–2026)

Table 50. Qiagen Recent Developments

Table 51. Tempus Basic Information List

Table 52. Tempus Description and Business Overview

Table 53. Tempus Genetic Disease Testing Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Genetic Disease Testing Business of Tempus (2021–2026)

Table 55. Tempus Recent Developments

Table 56. 23andme Basic Information List

Table 57. 23andme Description and Business Overview

Table 58. 23andme Genetic Disease Testing Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Genetic Disease Testing Business of 23andme (2021–2026)

Table 60. 23andme Recent Developments

Table 61. Veritas Genetics Basic Information List

Table 62. Veritas Genetics Description and Business Overview

Table 63. Veritas Genetics Genetic Disease Testing Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Genetic Disease Testing Business of Veritas Genetics (2021–2026)

Table 65. Veritas Genetics Recent Developments

Table 66. Myriad Genetics Basic Information List

Table 67. Myriad Genetics Description and Business Overview

Table 68. Myriad Genetics Genetic Disease Testing Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Genetic Disease Testing Business of Myriad Genetics (2021–2026)

Table 70. Myriad Genetics Recent Developments

Table 71. LabCorp Basic Information List

Table 72. LabCorp Description and Business Overview

Table 73. LabCorp Genetic Disease Testing Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Genetic Disease Testing Business of LabCorp (2021–2026)

Table 75. LabCorp Recent Developments

Table 76. Blueprint Genetics Basic Information List

Table 77. Blueprint Genetics Description and Business Overview

Table 78. Blueprint Genetics Genetic Disease Testing Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Genetic Disease Testing Business of Blueprint Genetics (2021–2026)

Table 80. Blueprint Genetics Recent Developments

Table 81. Illumina Basic Information List

Table 82. Illumina Description and Business Overview

Table 83. Illumina Genetic Disease Testing Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Genetic Disease Testing Business of Illumina (2021–2026)

Table 85. Illumina Recent Developments

Table 86. CENTOGENE Basic Information List

Table 87. CENTOGENE Description and Business Overview

Table 88. CENTOGENE Genetic Disease Testing Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Genetic Disease Testing Business of CENTOGENE (2021–2026)

Table 90. CENTOGENE Recent Developments

Table 91. GeneDx Basic Information List

Table 92. GeneDx Description and Business Overview

Table 93. GeneDx Genetic Disease Testing Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Genetic Disease Testing Business of GeneDx (2021–2026)

Table 95. GeneDx Recent Developments

Table 96. Fulgent Genetics Basic Information List

Table 97. Fulgent Genetics Description and Business Overview

Table 98. Fulgent Genetics Genetic Disease Testing Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Genetic Disease Testing Business of Fulgent Genetics (2021–2026)

Table 100. Fulgent Genetics Recent Developments

Table 101. BGI Genomics Basic Information List

Table 102. BGI Genomics Description and Business Overview

Table 103. BGI Genomics Genetic Disease Testing Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Genetic Disease Testing Business of BGI Genomics (2021–2026)

Table 105. BGI Genomics Recent Developments

Table 106. Revenue (US$ Million) in Genetic Disease Testing Business of Company 40 (2021–2026)

Table 107. Company 40 Recent Developments

Table 108. Key Raw Materials Lists

Table 109. Key Suppliers of Raw Materials Lists

Table 110. Genetic Disease Testing Downstream Customers

Table 111. Genetic Disease Testing Distributors List

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Genetic Disease Testing Product Picture

Figure 2. Global Genetic Disease Testing Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 4. Genetic Disease Testing Report Years Considered

Figure 5. Global Genetic Disease Testing Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Genetic Disease Testing Revenue in 2025

Figure 7. Genetic Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Direct Genetic Testing Picture

Figure 9. Indirect Genetic Testing Picture

Figure 10. Global Genetic Disease Testing Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Genetic Disease Testing Sales Value Market Share by Type, 2025 & 2032

Figure 12. Product Picture of Carrier Testing

Figure 13. Product Picture of Prenatal Testing

Figure 14. Product Picture of Newborn Screening

Figure 15. Product Picture of Others

Figure 16. Global Genetic Disease Testing Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Genetic Disease Testing Sales Value Market Share by Application, 2025 & 2032

Figure 18. North America Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 19. North America Genetic Disease Testing Sales Value by Country (%), 2025 vs 2032

Figure 20. Europe Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 21. Europe Genetic Disease Testing Sales Value by Country (%), 2025 vs 2032

Figure 22. Asia Pacific Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 23. Asia Pacific Genetic Disease Testing Sales Value by Subregion (%), 2025 vs 2032

Figure 24. South America Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 25. South America Genetic Disease Testing Sales Value by Country (%), 2025 vs 2032

Figure 26. Middle East & Africa Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 27. Middle East & Africa Genetic Disease Testing Sales Value by Country (%), 2025 vs 2032

Figure 28. Key Countries/Regions Genetic Disease Testing Sales Value (%), 2021–2032

Figure 29. United States Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 30. United States Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

Figure 31. United States Genetic Disease Testing Sales Value by Application (%), 2025 vs 2032

Figure 32. Europe Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 33. Europe Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

Figure 34. Europe Genetic Disease Testing Sales Value by Application (%), 2025 vs 2032

Figure 35. China Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 36. China Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

Figure 37. China Genetic Disease Testing Sales Value by Application (%), 2025 vs 2032

Figure 38. Japan Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 39. Japan Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

Figure 40. Japan Genetic Disease Testing Sales Value by Application (%), 2025 vs 2032

Figure 41. South Korea Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 42. South Korea Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

Figure 43. South Korea Genetic Disease Testing Sales Value by Application (%), 2025 vs 2032

Figure 44. Southeast Asia Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 45. Southeast Asia Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

Figure 46. Southeast Asia Genetic Disease Testing Sales Value by Application (%), 2025 vs 2032

Figure 47. India Genetic Disease Testing Sales Value (US$ Million), 2021–2032

Figure 48. India Genetic Disease Testing Sales Value by Type (%), 2025 vs 2032

Figure 49. India Genetic Disease Testing Sales Value by Application (%), 2025 vs 2032

Figure 50. Genetic Disease Testing Value Chain

Figure 51. Genetic Disease Testing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Genetic Disease Testing in 2032? zhanKai

The global market size of Genetic Disease Testing in 2032 was 2267 Million USD.

Which companies rank high in the global Genetic Disease Testing market? shouQi

What was the global market size of Genetic Disease Testing in 2026? shouQi

What is the annual compound growth rate of the global Genetic Disease Testing market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Genetic Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2267 million by 2032, at a CAGR of 11.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 145
USD 4900.00
(Single User License)
Global Genetic Disease Testing Market Research Report 2026
The global Genetic Disease Testing market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 2267 million by 2032, at a CAGR of 11.5% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 111
USD 2900.00
(Single User License)
Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Genetic Disease Testing market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 2267 million by 2032 with a CAGR of 11.5% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 94
USD 4250.00
(Single User License)
Global Genetic Disease Testing Market Insights, Forecast to 2031
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2054 million by 2031, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period.
Published Date: 2025-03-28
Pages: 132
USD 4900.00
(Single User License)
Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Genetic Disease Testing market size was US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 95
USD 4250.00
(Single User License)
Global Genetic Disease Testing Market Research Report 2025
The global market for Genetic Disease Testing was valued at US$ 1026 million in the year 2024 and is projected to reach a revised size of US$ 2054 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Published Date: 2025-03-28
Pages: 87
USD 2900.00
(Single User License)
Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genetic Disease Testing was estimated to be worth US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 101
USD 3950.00
(Single User License)

Global Genetic Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2267 million by 2032, at a CAGR of 11.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 145
USD 4900.00 (Single User License)
Global Genetic Disease Testing Market Research Report 2026
The global Genetic Disease Testing market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 2267 million by 2032, at a CAGR of 11.5% from 2026 to 2032.
Published: 2026-03-11
Pages: 111
USD 2900.00 (Single User License)
Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Genetic Disease Testing market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 2267 million by 2032 with a CAGR of 11.5% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 94
USD 4250.00 (Single User License)
Global Genetic Disease Testing Market Insights, Forecast to 2031
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2054 million by 2031, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period.
Published: 2025-03-28
Pages: 132
USD 4900.00 (Single User License)
Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Genetic Disease Testing market size was US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 95
USD 4250.00 (Single User License)
Global Genetic Disease Testing Market Research Report 2025
The global market for Genetic Disease Testing was valued at US$ 1026 million in the year 2024 and is projected to reach a revised size of US$ 2054 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Published: 2025-03-28
Pages: 87
USD 2900.00 (Single User License)
Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genetic Disease Testing was estimated to be worth US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 101
USD 3950.00 (Single User License)